These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Erythrocytes after cryopreservation with HES: molecular, structural and functional characteristics].
    Author: Henrich HA, Langer R.
    Journal: Zentralbl Chir; 1999; 124(4):271-7. PubMed ID: 10355080.
    Abstract:
    The use of hydroxyethylstarch (HES) as an alternative to glycerol for cryopreservation of erythrocytes is presented. Immediately after thawing erythrocytes showed alterations in the membrane skeleton and a lowered rigidity of their membrane. However, a few minutes after resuspension in a physiological salt solution the initial poicilocytosis changed back to normocytotic forms. Intravital microscopy of the dog's mesentery revealed a homogeneous distribution of labeled previously cryopreserved erythrocytes in the capillary bed. The lowering of the ATP-level in the erythrocyte by about 20 to 40% was seen to be harmless, because the ATP-turn over rate was unchanged and the glucose support by the GluT 1 carrier was seen to be guaranteed. There was no decrease in the 2,3-DPG level on one hand, but a shift to the right in the O2-association as well as dissociation functions; the saturation capacity of hemoglobin with O2 on the other hand was constant. Free radical oxygen species, generated as a consequence of the freezing/thawing process, were inactivated by the erythrocyte's own antioxidation system. The 24-hour post-transfusion survival in dog amounted to about 95% and the in vivo-life time was normal. The hemolysis of human erythrocytes after thawing was about 5%. Most methodological and scientific problems concerning erythrocyte cryopreservation are considered to be solved. After official permission for use in humans, major benefits to many fields in surgery are expected: no more short-cuts in blood supply, practically complete exclusion of infectious risks, even unlimited use of autologous blood.
    [Abstract] [Full Text] [Related] [New Search]